Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
Biomolecules · 2025
DOI: 10.3390/biom16010053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Yanhai Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Daping Hospital, Army Medical University, Chongqing 400042, China. Hauptthemen laut MEDLINE: Lipoylation, Skin Diseases. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Young Scientists Fund of National Natural Science Foundation of China, the Natural Science Foundation of Tibet Autonomous Region-General Project, the Science and Technology Innovation Enhancement Project of Army Medical University.
Abstract (Originalsprache)
Protein S-palmitoylation is a pivotal yet poorly integrated research field in dermatology. This reversible post-translational lipid modification primarily occurs on cysteine residues and is principally catalyzed by zinc finger and Asp-His-His-Cys DHHC-domain containing proteins (zDHHCs). The S-palmitoylation/depalmitoylation cycle directly affects protein localization, trafficking, stability, and protein–protein interaction, thereby regulating a variety of signaling pathways, including those mediating inflammation and immune reaction. Accumulating evidence has indicated that S-palmitoylation regulates various skin biological functions, including skin inflammation, skin barrier function, hair growth, and melanin synthesis, and is ultimately implicated in the initiation and development of massive dermatoses, such as alopecia and psoriasis. The recent development of new research tools, coupled with S-palmitoylation’s therapeutic potential, makes the timely synthesis of its role in skin pathophysiology both critical and opportune. Here, we summarize recent advances in understanding the mechanistic roles of S-palmitoylation in dermatological conditions and evaluate its potential as a therapeutic target for innovative treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Daping Hospital, Army Medical University, Chongqing 400042, China.
- Army 953 Hospital, Shigatse Branch of Xinqiao Hospital, Army Medical University, Shigatse 857000, China.
- Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University, Chongqing 400042, China.
- Air Force Hospital of Chinese PLA Central Theater Command, 589 Yunzhong Road, Pingcheng District, Datong 037006, China.
Förderung
- the Young Scientists Fund of National Natural Science Foundation of China
- the Natural Science Foundation of Tibet Autonomous Region-General Project
- the Science and Technology Innovation Enhancement Project of Army Medical University
- Natural Science Foundation of Chongqing
- Young Scientists Fund of National Natural Science Foundation of China
- Natural Science Foundation of Tibet Autonomous Region-General Project
- Science and Technology Innovation Enhancement Project of Army Medical University
Zitieren
APA
Feng, Y., Wu, J., Tang, H., Liu, S., Jia, H., Liang, Y., Li, Z., Li, L., Li, L., & Lei, X. (2025). Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses. Biomolecules. https://doi.org/10.3390/biom16010053
Vancouver
Feng Y, Wu J, Tang H, Liu S, Jia H, Liang Y, et al. Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses. Biomolecules. 2025. doi:10.3390/biom16010053
BibTeX
@article{Feng2025,
author = {Feng, Yanhai and Wu, Jianxin and Tang, Hui and Liu, Shunying and Jia, Honglin and Liang, Yi and Li, Zhenglin and Li, Lingbo and Li, Lingfei and Lei, Xia},
title = {Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom16010053}
}
EUVIMED